You are here

  • Home
  • Archive
  • Volume 8, Issue 9
  • Impact of PCSK9 monoclonal antibodies on circulating hs-CRP levels: a systematic review and meta-analysis of randomised controlled trials

Article metrics

Article menu

Download PDFPDF

XML
Cardiovascular medicine
Research
Impact of PCSK9 monoclonal antibodies on circulating hs-CRP levels: a systematic review and meta-analysis of randomised controlled trials

 

Online download statistics by month:

Online download statistics by month: October 2018 to April 2024

AbstractFullPdf
Oct 201823623377
Nov 201814914910
Dec 201816016011
Jan 2019717112
Feb 201966658
Mar 2019393923
Apr 201918188
May 2019434229
Jun 2019302944
Jul 2019363657
Aug 2019302846
Oct 2019353457
Nov 2019252547
Dec 2019434337
Jan 2020555528
Feb 2020444343
Mar 2020343443
May 2020222238
Jun 2020232329
Jul 2020222224
Aug 2020212019
Sep 2020333033
Oct 2020403724
Nov 2020302320
Dec 2020242315
Jan 202133239
Feb 2021171510
Mar 2021262417
Apr 2021211713
May 2021343011
Jun 2021353014
Jul 202119175
Aug 2021191611
Sep 2021495110
Oct 2021343130
Nov 2021272322
Dec 202131307
Jan 2022303012
Feb 202234268
Mar 2022373418
Apr 2022424123
May 2022615622
Jun 2022453717
Jul 2022444010
Aug 2022262211
Sep 2022141253
Oct 2022211911
Nov 2022393824
Dec 2022312810
Jan 2023373524
Feb 2023433716
Mar 2023544720
Apr 2023222014
May 2023373620
Jun 202319147
Jul 2023303023
Aug 2023191816
Sep 202318168
Oct 2023282911
Nov 202330256
Dec 2023494814
Jan 2024272710
Feb 202425236
Mar 2024252317
Apr 202419178
Total258024391380